Earnings Preview: What to Expect From Viatris' Report

Viatris Inc. (VTRS), headquartered in Canonsburg, Pennsylvania, operates as a healthcare company. With a market cap of $20.7 billion, the company produces medicines for patients across broad range of major therapeutic areas spanning both noncommunicable and infectious diseases. The global healthcare giant is expected to announce its fiscal third-quarter earnings for 2026 before the market opens on Thursday, Nov. 5.

Ahead of the event, analysts expect Viatris to report a profit of $0.64 per share on a diluted basis, down 4.5% from $0.67 per share in the year-ago quarter. The company has consistently surpassed Wall Street’s EPS estimates in its last four quarterly reports. 

For the full year, analysts expect Viatris to report EPS of $2.51, up 6.8% from $2.35 in fiscal 2025. Its EPS is expected to rise 9.2% year over year to $2.74 in fiscal 2027. 

VTRS stock has considerably outperformed the S&P 500 Index’s ($SPX) 13% gains over the past 52 weeks, with shares up 76.7% during this period. Similarly, it notably outperformed the State Street Health Care Select Sector SPDR ETF’s (XLV) 22.8% returns over the same time frame.

Viatris delivered a solid performance driven by double-digit commercial growth in Greater China, robust demand for complex generics in North America, and disciplined cost control. While near-term headwinds from supply chain disruptions and China’s policy changes weighed on margins, the company is positioning itself for long-term growth through key pipeline catalysts, including recent approvals for the GwynLo patch and WAKIX in Japan, alongside portfolio-reshaping moves like the divestment of Tyrvaya and its Biocon stake.

Analysts’ consensus opinion on VTRS stock is reasonably bullish, with a “Moderate Buy” rating overall. Out of 11 analysts covering the stock, six advise a “Strong Buy” rating, four give a “Hold,” and one recommends a “Moderate Sell.” VTRS’ average analyst price target is $20.36, indicating a potential upside of 11.3% from the current levels.